Skip to main content
. 2022 Aug 19;11(8):1601. doi: 10.3390/antiox11081601

Table 4.

Initial concentrations and microdilutions for standard antibacterial and antifungal drugs, positive control, and sample.

Micro-
Dilution
CTR (mg/mL) TRF (mg/mL) P407 (mg/mL) F-UBO (mg/mL)
30.230 ± 0.630 122.330 ± 0.850 10.050 ± 0.180 50.133 ± 1.305 63.533 ± 1.955
1 1.511 ± 0.043 6.117 ± 0.042 0.500 ± 0.009 2.506 ± 0.065 3.176 ± 0.097
2 0.755 ± 0.022 4.893 ± 0.034 0.250 ± 0.004 1.253 ± 0.032 1.588 ± 0.048
3 0.377 ± 0.011 3.914 ± 0.027 0.125 ± 0.002 0.626 ± 0.016 0.794 ± 0.024
4 0.188 ± 0.005 3.131 ± 0.021 0.061 ± 0.001 0.315 ± 0.008 0.397 ± 0.012
5 0.094 ± 0.002 2.505 ± 0.017 0.031 ± 0.001 0.157 ± 0.004 0.199 ± 0.008
6 0.047 ± 0.002 2.004 ± 0.014 0.015 ± 0.001 0.078 ± 0.002 0.100 ± 0.004
7 0.023 ± 0.001 1.603 ± 0.011 0.007 ± 0.001 0.039 ± 0.001 0.049 ± 0.002

CTR—ceftriaxone; TRF—terbinafine; P407—poloxamer 407; F-UBO—bioadhesive oral films with U. barbata extract in canola oil.